| (USD) | Dec 2025 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | 0.00 | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, NRSN returned -67.9% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -51.1% |
| 1 year | -67.9% |
| All-time high | $3.97 (Mar 2022) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in NRSN would be worth today ›No. NeuroSense Therapeutics Ltd. has not paid a dividend in the past 12 months.
NeuroSense Therapeutics Ltd. stock trades on NASDAQ under the ticker symbol NRSN.
NeuroSense Therapeutics Ltd. is part of the Healthcare sector.
NeuroSense Therapeutics Ltd. has a market cap of 14.21M USD, based on the latest quote.
